Glycosylation of DBP through the combined action of a betagalactosidase and a sialidase engenders the Gc macrophage activating factor (GcMAF), the most potent activator of macrophages with an important role in immune system regulation and anti-angiogenetic activity in cancer patients [34, 38]. Here, GLB1 is linked to cancer.